Skip to main content
SpringerLink
Log in

Andere Sekretionshemmer und Medikamente zur Förderung der Schleimhautresistenz

  • Conference paper
Ulcus-Therapie

Part of the book series: Interdisziplinäre Gastroenterologie ((GASTROENTEROLOG))

  • 24 Accesses

Zusammenfassung

Die Ulcustherapie verfolgt das Ziel, das gestörte Gleichgewicht zwischen defensiven und aggressiven Faktoren zugunsten der defensiven Faktoren zu verschieben. Dabei kann die Hemmung der aggressiven Elemente ebenso Erfolg haben wie die Förderung der defensiven (Abb. 1). Die Hemmung der aggressiven Faktoren ist gleichbedeutend mit einer Verminderung der Wasserstoffionen- und/oder Pepsinkonzentration in der Umgebung des Geschwürs — sei es durch Hemmung der Sekretion oder durch Inaktivierung des Sekrets. Die an der Belegzelle angreifenden Histaminantagonisten werden in Kap. 15 und die Antacida in Kap. 14 besprochen. Im folgenden wird auf die übrigen Sekretionshemmer eingegangen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alberdi Frias, J., Guemes Diaz, F., Perez Mota, A. (1978): A double blind study of trithiozine in peptic ulcer. Clin. Ther. 1, 251 (1978)

    Google Scholar 

  2. Amure, O.: Anticholinergic drugs in the management of duodenal ulcer. Practitionier 195, 335–339 (1965)

    CAS  Google Scholar 

  3. Archambault, A., Farley, A., Gosselin, D., Martin, F., Birkett, J.P.: Evaluation of duogastrone (carbenoxolone sodium) for the treatment of duodenal ulcer: A multicentre study. Can. Med. Assoc. 117, 1155–1159 (1977)

    CAS  Google Scholar 

  4. Asano, T.: Study of gastric blood flow. VI. Congress Ther Res. New Drugs. Osaka 1969. Rep. Vol., pp. 108–122

    Google Scholar 

  5. Banks, S., Mark, I.W.: Maintainance carbenoxolone sodium in the prevention of gastric ulcer recurrence. In: Carbenoxolone Sodium Symposium at the Fourth World Congress of Gastroenterology. Baron, J.H., Sullivan, F.M. (eds.), pp. 103–106. London: Butterworths 1970

    Google Scholar 

  6. Barbara, L., Corinaldesi, R., Miglioli, M. et al.: Efficacia terapeutica della tritiozina (ISF 2001) nelle affezioni gastroduodenali. Minerva Gastroenterol. 21, 169 (1975)

    PubMed  CAS  Google Scholar 

  7. Baume, P.E„ Hunt, J.H., Piper, D.W.: Glycopyrronium bromide in the treatment of chronic gastric ulcer. Gastroenterology 63, 399–406 (1972)

    PubMed  CAS  Google Scholar 

  8. Bayliss, W.M., Starling, E.H.: The mechanism of pancreatic secretion. J. Physiol. 28, 325–335 (1902)

    PubMed  CAS  Google Scholar 

  9. Becker, H.D.: Sekretin in der Behandlung der akuten Magenblutung. In: Internationales Symposium über Histamin-H2-Receptor-Antagonisten. Creutzfeldt, W. (Hrsg.), S. 292–296. Amsterdam: Excerpta Medica 1978

    Google Scholar 

  10. Beermann, B., Hellström, K., Rosén, A.: The gastrointestinal absorption of atropine in man. Clin. Sci. 40, 95 (1971)

    PubMed  CAS  Google Scholar 

  11. Beermann, B., Hellström, K., Rosén, A.: The effect of long-term administration in the absorption of methylscopolamine in man. Acta Med. Scand. 193, 35 (1973)

    Article  PubMed  CAS  Google Scholar 

  12. Belsasso, E., Caenazzo, E., Visintini, E.: Efficacia terapeutica della tritiozina nell’ulcera duodenale. Ricera controllata in doppio cieco. Clin. Eur. 17, 3 (1978)

    Google Scholar 

  13. Bennet, A.: Prostaglandins and the alimetary tract. In: Prostaglandins: Physiological pharmacological and pathological aspects. Karim, S.M.M. (eds.), pp. 247–276. Lancaster: MTP Press 1976

    Google Scholar 

  14. Bennett, A.: Prostaglandins and the gut. In: Annual research reviews. Horrobin, D.F. (eds)., Montreal Eden Press 1976

    Google Scholar 

  15. Bereti, I.: Effects of trithiozine (ISF 2001) on duodenal ulcer: A controlled double blind trial. Farmaco Ed. Prat. 31, 495 (1976)

    CAS  Google Scholar 

  16. Bereti, I.: Comparison between the activities of trithiozine (ISF 2001) and atropine on human gastric secretion. Riv. Farmacol. Ter. 8, 139 (1977)

    Google Scholar 

  17. Bergemann, W.: Duodenal ulcer - multicenter double blind study with proglumide. Med. Klin. 76, 226–229 (1981)

    PubMed  CAS  Google Scholar 

  18. Bertaccini, G.: Effects of trithiozine on histamine H2-receptors. Ber. J.S.F. (1978)

    Google Scholar 

  19. Caldara, R., Romussi, M., Ferrari, C.: Inhibition of gastrin secretion by sulpiride treatment in duodenal ulcer patients. Gastroenterology 74, 221–223 (1978)

    PubMed  CAS  Google Scholar 

  20. Cambielli, M., Evangelista, A., Guslandi, M., Bierti, L., Benvenuti, C., Tittobello, A.: Double blind comparison between cimetidine and gefarnate in cases of duodenal ulcer. Acta Hepatogastroenterol. (Stuttg.) 26, 326–330 (1979)

    CAS  Google Scholar 

  21. Catalano, F., Brogna, A., Blasi, A.: Tritiozina e ulcera peptica: ricerca clinica in doppio cieco. Minerva Dietol. Gastroenterol. 23, 1 (1977)

    Google Scholar 

  22. Cheli, R., Ciancamerla, G., Giacosa, A. et al.: Short-term cimetidine treatment of duodenal ulcer. Comparison with placebo and an anticholinergic drug. Ital. J. Gastroenterol. 10, 18 (1978)

    Google Scholar 

  23. Cheli, R., Giacosa, A., Perasso, A.: Tritiozine and gastrinemia. Clin. Ter. 2, 106 (1979)

    Google Scholar 

  24. Chey, W.Y., Rhodes, R.A., Tai, H.-H.: Role of secretin in man. II. In: Gut hormones. Bloom, S.R. (eds.), pp. 193–196. London: Churchill Livingstone 1978

    Google Scholar 

  25. Cifarelli, A., Setnikar, I., Vidal y Plana, R.R.: Antagonism of proglumide to human gastrin at sites on gastric cell membranes. In: Proglumide-gastrin-receptor antagonist. Weiss, J., Miederer, S.E. (eds.), pp. 13–21. Amsterdam: Excerpta Medica 1980

    Google Scholar 

  26. Cocking, J.B.: A trial of amylopectin sulphate (SN-263) and propantheline bromide in the long term treatment of chronic duodenal ulcer. Gastroenterology 62, 6–10 (1972)

    PubMed  CAS  Google Scholar 

  27. Cocking, J.B., McCaig, J.B.: Effect of low dosage of carbenoxolone sodium on gastric ulcer healing and acid secretion. Gut 10, 219–225 (1969)

    Article  PubMed  CAS  Google Scholar 

  28. Collyns, A.H., Fordtran, J.S.: Controlled analysis of antacids and anticholinergics in modifying gastric acidity and peptic activity after steak in patients with duodenal ulcer. Gastroenterology 48, 812 (1965)

    Google Scholar 

  29. Corazza, G.R., D’Ambro, A., Grimoldi, D.: Studio in doppio cieco dei farmaci proglumide, zolimidina e carbenoxolone nell’ulcera peptica e nelle gastroduodeniti. Minerva Dietol. Gastroenterol. 24, 47 (1979)

    Google Scholar 

  30. Corinaldesi, R., Luchetta, L., Ricci, P. et al.: Valutazione dell tollerabilità, a lungo termine, della tritiozina (ISF 2001), Farmaco Ed. Prat. 32. 25 (1977)

    CAS  Google Scholar 

  31. Corinaldesi, R., Luchetta, L., Ricci, P. et al.: Cross-over clinical comparison between antisecretory activity of propantheline bromide and trithiozine (ISF 2001). Panminerva Med. 19, 339 (1977)

    PubMed  CAS  Google Scholar 

  32. Corinaldesi, R., Luchetta, L., Ricci, P., et al.: Effects of trithiozine (ISF 2001) on gastric secretion in man. Riv. Farmacol. Ter. 8, 113 (1977)

    Google Scholar 

  33. Corinaldesi, R., Miglioli, M., Cornelli, U. et al.: Effect of trithiozine on 24-hour gastric aciditiy in duodenal ulcer patients. Rend. Gastroenterol. 9, 20 (1977)

    Google Scholar 

  34. Cornel, A., Griveaux, M.: Recherches physiopathologiques sur le sulpiride en gastroentérologie. Bull. Mem. Soc. Med. Hop. 119, 753–760 (1968)

    Google Scholar 

  35. Davies, W.A., Reed, P.I., Controlled trial of duogastrone in duodenal ulcer. Gut 18, 78 (1977)

    Article  PubMed  CAS  Google Scholar 

  36. Demling, L., Domschke, W., Riemann, J.F., Domschke, S., Ruppin, J., Junge, O., Wuensch, E.: Gastrointestinal effects of long term treatment of duodenal ulcer with depot secretin: Clinical, secretory, ultrastructural, and enzymological aspects. Scand. J. Gastroenterol. [Suppl.42] 2, 135–145 (1976)

    Google Scholar 

  37. Di Mario, F. et al.: Multicentric study of the use of thiopropamine in therapy of duodenal ulcer. Clin. Ter. 93, 389–400 (1980)

    PubMed  Google Scholar 

  38. Dobrilla, G., Filippini, M., Valentini, M. et al.: Effect of a new gastric antisecretory compound, trithiozine, on pancreatic secretion in control subjects and patients affected by duodenal ulcer. Acta Ther. 3, 247 (1977)

    Google Scholar 

  39. Doll, R.: Medical treatment of gastric ulcer. Scott. Med. J. 9, 183–196 (1964)

    PubMed  CAS  Google Scholar 

  40. Doll, R., Hill, I.D., Hutton, C., Underwood, D.J.: Clinical trial of a triterpenoid liquorice compound in gastric and duodenal ulcer. Lancet 1962 II, 793–796

    Google Scholar 

  41. Doll, R., Hill, I.D., Hutton, C.F.: Treatment of gastric ulcer with carbenoxolone sodium and oestrogen. Gut 6, 10–24 (1965)

    Article  Google Scholar 

  42. Domschke, W., Domschke, S., Hagel, J., Demling, L., Croft, D.N.: Gastric epithelial cell turnover, mucus production, and healing of gastric ulcers with carbenoxolone. Gut 18, 817–820 (1977)

    Article  PubMed  CAS  Google Scholar 

  43. Domschke, W., Domschke, S., Hornig, D., Demling, L.: Prostaglandin-stimulated gastric mucus secretion in man. Acta Hepatogastroenterol. (Stuttg.) 25, 292–294 (1978)

    CAS  Google Scholar 

  44. Dotevall, G.: Comment. Selected summaries. Gastroenterology 60, 1142–1143 (1971)

    Google Scholar 

  45. Dotevall, G., Walan, A.: Antacids in the treatment of peptic ulcer. Acta Med. Scand. 182, 529 (1967)

    Article  PubMed  CAS  Google Scholar 

  46. Dotevall, G., Schröder, G., Walan, A.: The effect of poldine, glycopyriolate, and 1- hyoscyamine on gastric secretion of acid in man. Acta Med. Scand. 177, 169–174 (1965)

    Article  PubMed  CAS  Google Scholar 

  47. Enoch, W.: Die Wirkung von Proglumid (Milid) auf Magen- und Zwölffingerdarmge- schwüre. Vergleich mit einer kombinierten Antazida-Anticholinergika-Behandlung. Inf. Arzt 8, 64 (1980)

    Google Scholar 

  48. Feldmann, H., Gilat, T.: A trial of deglycyrrhizinated liquorice in the treatment of duodenal ulcer. Gut 12, 449–451 (1971)

    Article  Google Scholar 

  49. Feldman, M., Richardson, C.T., Peterson, W.L., Walsh, J.H., Fordtrans, D.S.: Effect of low-dose propantheline on food-stimulated secretion. N. Engl. J. Med. 297, 1427–1430 (1977)

    Article  PubMed  CAS  Google Scholar 

  50. Fellenius, E., Elander, B., Wallmark, B., Haglund, U., Olbe, L., Heiander, H.: Studies on acid secretory mechanism and drug action in isolated gastric glands from man. In: Hormone receptors in digestion and nutrition. Rosselin, G., Fromageot, P., Bonfils, S. (eds.), pp. 355–360. Amsterdam: Elsevier/North-Holland, Biomedical Press 1979

    Google Scholar 

  51. Fellenius, E., Berghlind, T., Sachs, G., Olbe, L., Elander, B., Sjöstrand, S.E., Wall- mark, B.: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+/ K+)-ATPase. Nature 290, 159–161 (1981)

    Article  PubMed  CAS  Google Scholar 

  52. Fichera, G., Calliera, M., Maroni, G.C., Mirelli, E.: La tritiozina (ISF 2001) nell duo-denopatie. Studio clinico, endoscopico e funzionale. Arch. Ital. Mai. Appar. Dig. 37, 201 (1976)

    Google Scholar 

  53. Fordtran, J.S., Collyns, J.A.: Antacid pharmacology in duodenal ulcer. Effects of antacids on postcibal gastric acidity and peptic activity. N. Engl. J. Med. 274, 921 (1966)

    Article  PubMed  CAS  Google Scholar 

  54. Fossati, C.: Valutazione clinica controllata dell’attività terapeutica nell’ulcera peptica di tre farmaci antiulcerosi: sodio carbenoxolone, proglumide e zolimidina. Clin. Ter. 80, 605 (1979)

    Google Scholar 

  55. Fräser, P.M., Doli, R., Langman, M.J.S. et al.: Clinical trial of a new carbenoxolone analogue BX-24, zinc sulphate and vitamin A in the treatment of gastric ulcer. Gut 13, 459 (1972)

    Article  PubMed  Google Scholar 

  56. Fung, W.P., Karim, S.M.M.: Effect of 15(R) 15 methyl prostaglandin E2 on the healing of gastric ulcers: A double-blind endoscopic study. Med. J. Aust. 2, 127–128 (1976)

    PubMed  CAS  Google Scholar 

  57. Fung, W.P., Karim, S.M.M.: Effect of prostagland in E2 on the healing of gastric ulcers: A double-blind endoscopic trial. Aust. N.Z.J. Med. 6, 121–122 (1976)

    Article  PubMed  CAS  Google Scholar 

  58. Fung, W.P., Karim, S.M.M., Tye, C.Y.: Double-blind trial of 15(R)-15 methyl Prostaglandine E2 methyl ester in the relief of peptic ulcer pain. Ann. Acad. Med. 3, 375 (1974)

    Google Scholar 

  59. Gibiński, K., Rybicka, J., Mikos, E., Novak., A.: Double-blind clinical trial on gastro- duodenal ulcer healing with prostaglandin E2 analogues. Gut 18, 636–639 (1977)

    Article  PubMed  Google Scholar 

  60. Gottrup, F., Ornsholt, J.: Effects of a β2-sympathomimetic on histamine-stimulated gastric acid secretion in dogs. Scand. J. Gastroenterol. 14, 321 (1979)

    Article  PubMed  CAS  Google Scholar 

  61. Goyal, R.K., Bhardway, O.P., Chuttani, H.K.: Parasympatholytic agents in duodenal ulcer. Double blind controlled trial with oxyphencyclimine hydrochloride. Indian Med. Assoc. J. 50, 365–367 (1968)

    CAS  Google Scholar 

  62. Guth, P.H., Aures, D., Paulsen, G.: Tropical aspirin plus HCl gastric lesions in the rat. Gastroenterology 76, 88 (1979)

    PubMed  CAS  Google Scholar 

  63. Gütz, H.J., Berndt, H., Jackson, D.: The treatment of gastric ulcer: A comparative trial of four preparations. Practitioner 222, 849–853 (1979)

    PubMed  Google Scholar 

  64. Hayes, M.J., Spackling, M.E., Langman, M.J.S.: Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship to advers drug effects. Gut 18, 1054 (1977)

    Article  PubMed  CAS  Google Scholar 

  65. Herrerias Gutierrez, J.M., Carrido Peralta, M.: La tritiozina nell’ulcera peptica: studio clinico controllato. Clin. Ter. 88, 363 (1979)

    PubMed  CAS  Google Scholar 

  66. Hogita, K., Okundo, T., Igiri, Y., Tosa, M.: Erfahrungen mit Proglumid bei Magenerkrankungen. Nachweis der Wirkung auf Magenulcera mittels der Doppelblindmethode. Shinyaku To Rinsho 19, 1185 (1970)

    Google Scholar 

  67. Horwich, L., Galloway, R.: Treatment of gastric ulceration with carbenoxolone sodium: Clinical and radiological evaluation. Br. Med. J. 1976 II, 1274–1277

    Google Scholar 

  68. Hoskins, E.O.L.: Metoclopramide in benigne gastric ulceration. Postgrad. Med. J. [Suppl.4] 49, 95–97 (1973)

    PubMed  Google Scholar 

  69. Hunt, T., Abrams, M., Atkinson, M.: Carbenoxolone in the treatment of duodenal ulcer. A multicentre trial. Br. J. Clin. Pract. 27, 50–55 (1973)

    Google Scholar 

  70. Inoue, K., Sekine, S., Okabe, Y., Kato, T., Izumiya, A.: Concomitant use of proglumide and glycopyrronium bromide in peptic ulcers. Igaku To Yakugaku 1, 417 (1979)

    Google Scholar 

  71. Ippoliti, A.F., Isenberg, J.I., Hagie, L.: Effect of oral and intravenous 16, 16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Gastroenterology 80, 55–59 (1981)

    PubMed  CAS  Google Scholar 

  72. Itoh, T., Tatsuta, M., Yamamura, T., Bada, M., Tamusa, H.: A consideration on the effects of proglumide on the gastric acid secretion. Rinsho To Kenkyu 56, 308 (1980)

    Google Scholar 

  73. Kauffman, G.L., Reeve, J.J., Grossman, M.I.: Gastric bicarbonate secretion: Effect of topical and intravenous 16, 16-dimethyl Prostaglandine E2. Am. J. Physiol. 239, 644–648 (1980)

    Google Scholar 

  74. Kaura, R., Allen, A., Hirst, B.H.: Secretin stimulation of high viscosity mucus glycoprotein aggregates in gastric juice (Abstr.). Gut 22, A 882 (1981)

    Google Scholar 

  75. Kayasseh, L., Gyr, K., Keller, G., Stalder, A., Wall, M.: Somatostatin and Cimetidine in peptic ulcer hemorrhage. A randomized controlled trial. Lancet 1980 I, 844

    Google Scholar 

  76. Kaye, M.D.: Anticholinergic drugs in duodenal ulcer. Gastroenterology 62, 502–504 (1972)

    PubMed  CAS  Google Scholar 

  77. Kaye, M.D., Rhodes, J., Beck, P. et al.: A controlled trial of glycopyrronium and 1- hyoscyamine in the long term treatment of duodenal ulcer. Gut 11, 559–566 (1970)

    Article  PubMed  CAS  Google Scholar 

  78. Keyriläinen, O., Uusitalo, A.: The influence of an anticholinergic agent on the duration of the effect of antacids. In: Abstracts of Papers from the XIIth Scandinavian Conference on Gastroenterology 24–26 August, 1978. Ihse, I. (ed.), p. 59

    Google Scholar 

  79. Knego, Z.: Vagotomia superselettiva e trattamento con ISF 2001 (tritiozina) confronto degli effetti sulla secrezione gastrica. Arch. Ital. Mai. Appar. Dig. 37, 213 (1976)

    Google Scholar 

  80. Koelz, H.R., Fischer, J., Sachs, G., Blum, A.L.: A specific action of aspirin on gastric cell membrane. Gastroenterology 72, A-59/1082 (1977)

    Google Scholar 

  81. Kollberg, B., Johansson, C., Slezak, P.: Duodenal ulcer healing with Prostaglandine E2 (Abstr.). Gastroenterology 80, 1195 (1981)

    Google Scholar 

  82. Konturek, T., Radecki, T., Demitrescu, N. et al.: Effect of synthetic 15-methyl analog of prostaglandin E2 on gastric secretion and peptic ulcer formation. J. Lab. Clin. Med. 84, 716 (1974)

    PubMed  CAS  Google Scholar 

  83. Kramer, A.: Die Therapie des gastroduodenalen Ulkus mit Proglumid. Therapiewoche 30, 225 (1980)

    Google Scholar 

  84. Lam, S.K., Lam, K.C., Lai, C.L. et al.: Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. Gastroenterology 76, 315 (1979)

    PubMed  CAS  Google Scholar 

  85. Leading article: Anticholinergics and duodenal ulcer. Lancet 1973 II, 1173

    Google Scholar 

  86. Lehtola, J., Karvonen, A.L., Tunturi-Hihnala, H.: Double-blind study of carbenoxolone in gastric ulcer and erosions. Ann. Clin. Res. 10, 19–23 (1978)

    PubMed  CAS  Google Scholar 

  87. Lennard-Jones, J.E.: Experimental and clinical observations on Poldine in treatment of duodenal ulcer. Br. Med. J. 1961 I, 1071–1076

    Google Scholar 

  88. Londong, W., Hasford, J., Sander, R., Sommerlatte, T., Überla, K., Ultsch, B., Weinzirl, M.: Kombination von Cimetidin und Pirenzepin zur Rezidivprophylaxe der akuten gastroduodenalen Blutung—eine multizentrische Doppelblindstudie (Abstr.) Z. Gastroenterol. 20, 1982

    Google Scholar 

  89. Magous, R., Bali, J.P.: Influence of proglumide on 125-I-gastrin binding to isolated cells from rat gastric mucosa. In: Proglumide Proceedings of the 4th International Symposium. Weiss, J., Miederer, S.E. (eds.), pp. 1–9. Amsterdam: Excerpta Medica 1980

    Google Scholar 

  90. Mahl, G.F.: Anxiety, HCl-secretion, and peptic ulcer etiology. Psychosom. Med. 12, 158–169 (1950)

    PubMed  CAS  Google Scholar 

  91. Major, J.S., Scholes, P.: The localisation of a histamine H2-receptor adenylate cyclase system in canine parietal cells and its inhibition by prostaglandins. Agents Actions 8, 324 (1978)

    Article  PubMed  CAS  Google Scholar 

  92. Margolin, S.G.: The behavior of the stomach during psychoanalysis. A contribution to a method of verifying psychoanalytic data. Psychoanal. Q. 20, 349–357 (1951)

    PubMed  CAS  Google Scholar 

  93. Masuda, M.: Results of a national scale statistical study of a double blind study. VI. Congress Ther. Res. New Drugs, Osaka, Rep. Vol. 1–20 (1969)

    Google Scholar 

  94. McCarthy, D.M., M.Sc., F.A.C.P.: Report in the United States experience with Cimetidine in Zollinger-Ellison syndrome and other hypersecretory states. Gastroenterology 74, 453–458 (1978)

    PubMed  CAS  Google Scholar 

  95. Melrose, A.G., Pinkerton, I.W.: Clinical evaluation of poldine methosulphate. Br. Med. J. 1961 II, 1076–1078

    Google Scholar 

  96. Middleton, W.R.J., Cooke, A.R., Stephen, D., Skyring, A.P.: Biogastrone in inpatient treatment of gastric ulcer. Lancet 1965 I, 1030–1032

    Google Scholar 

  97. Miederer, S.E., Lindstaedt, H., Kutz, K., Wuttke, H.: Wirksame ambulante Therapie des Ulcus ventriculi mit Proglumid. Dtsch. Med. Wochenschr. 104, 313 (1979)

    Article  PubMed  CAS  Google Scholar 

  98. Miller, T.A., Jacobson, E.D.: Gastrointestinal cytoprotection by prostaglandins. Gut 20, 75–87 (1979)

    Article  PubMed  CAS  Google Scholar 

  99. Misiewicz, J.J., Russell, R.I., Baron, J.H.: Treatment of duodenal ulcer with glycyrrhizinic-acid-reduced liquorice. A multicentre trial. Br. Med. J. 3, 501–503 (1971)

    Article  Google Scholar 

  100. Mitchell, R.D., Hunt, J.W., Grossman, M.I.: Inhibition of basal and postprandial gastric secretion by poldine and atropine in patients with peptic ulcer. Gastroenterology 43, 400–406 (1962)

    Google Scholar 

  101. Molle, M.: Sulpirid bei der Behandlung von Gastroduodenalgeschwüren. Fortschr. Med. 93, 1077–1082 (1975)

    PubMed  CAS  Google Scholar 

  102. Montgomery, R.D., Cookson, J.B.: Comparative trial of carbenoxolone and a degly-cyrrhizinated liquorice preparation (Caved-S). Clin. Trials. J. 9, 33 (1972)

    Google Scholar 

  103. Müller, J.E., Fritsch, W.P., Hengeis, K.J., Schölten, T.: Plasmasekretin und Gastrin sowie Bicarbonatsekretion nach Depot-Sekretion (Abstr.). Acta Hepatogastroenterol. (Stuttg.) 27 (1980)

    Google Scholar 

  104. Nagy, G.S.: Evaluation of carbenoxolon sodium in the treatment of duodenal ulcer. Gastroenterology 74, 7–10 (1978)

    PubMed  CAS  Google Scholar 

  105. Nylander, B., Anderson, S.: Gastric secretory inhibition induced by three methyl analogs of prostaglandin E2 administered intragastrically to man. Scand. J. Gastroenterol. 9, 751 (1974)

    PubMed  CAS  Google Scholar 

  106. Olbe, L., Berghlind, T., Elander, B. et al.: Properties of a new class of gastric acid inhibitors. Scand. J. Gastroenterol. [Suppl.] 55, 131–133 (1979)

    CAS  Google Scholar 

  107. Ottenjann, R., Rösch, W.: Clinical and experimental studies on carbenoxolon sodium. In: Carbenoxolon sodium. Baron, J.H., Sullivan, F.M. (eds.), pp. 75–79. London: But- terworths 1970

    Google Scholar 

  108. Ponti, V., Pera, A., Verme, C.: Ricerca clinica comparative sulla tritiozina e la cimetidina nell’ulcera duodenale. Clin. Ter. 89, 299 (1979)

    PubMed  CAS  Google Scholar 

  109. Post, C., Walan, A.: Influence of food on the effect of L-hyoscyamine and ben- ziloniumbromide. Scand. J. Gastroenterol. [Suppl. 45] 12, 72 (1977)

    Google Scholar 

  110. Pratt, C.L.G.: The influence of secretin on gastric secretion. J. Physiol. 98, 1–2 (1940)

    CAS  Google Scholar 

  111. Robert, A.: The inhibitory effects of prostaglandins on gastric secretion: Their possible role in the treatment of gastric hypersecretion and peptic ulcer. Prog. Gastroenterol. 3, 777–801

    Google Scholar 

  112. Robert, A.: Prostaglandins: Their effect on the digestive system. Viewpoints Dig. Dis. 2, 1 (1979)

    Google Scholar 

  113. Rothmund, M., Wagner, P.K.: Wirkung von Cimetidin und Sekretin bei akuten Blutungen aus gastroduodenalen Ulcera und Erosionen. Dtsch. Med. Wochenschr. 107, 245–248 (1982)

    Article  PubMed  CAS  Google Scholar 

  114. Rovati, A.L.: Inhibition of gastric secretion by anti-gastrinic and H-2-blocking agents. Scand. J. Gastroenterol. [Suppl.42] 11, 113 (1976)

    CAS  Google Scholar 

  115. Rybicka, J., Gibinski, K.: Methyl-prostaglandin analogues for healing of gastro-duo- denal ulcers. Scand. J. Gastroenterol. 13, 155–159 (1978)

    Article  PubMed  CAS  Google Scholar 

  116. Saccomani, G., Heiander, H.F., Crago, S., Chang, H., Dailey, D.W., Sachs, G.: Characterization of gastric mucosal membranes. Immunological studies of gastric (H + + K+-ATPase. J. Cell. Biol. 83, 271–283 (1979)

    Article  PubMed  CAS  Google Scholar 

  117. Sahel, J., Sarles, H., Boisson, J. et al.: Carbenoxolone sodium capsules in the treatment of duodenal ulcer. An endoscopic controlled trial. Gut 18, 717–720 (1977)

    Article  Google Scholar 

  118. Schölten, T. Frisch, W.-P., Hausamen, T.U., Lingenberg, G., Rick, W.: Treatment of duodenal ulcer with long acting synthetic secretin. Gastroenterology 72/A-13, 823

    Google Scholar 

  119. Schölten, T., Fritsch, W.P., Müller, J.E., Hengeis, K.J.: Langzeitsuppression der H+-Sekretion durch Kombination von Cimetidin und Methanthelinbromid. Dtsch. Med. Wochenschr. 104, 1849–1853 (1979)

    Article  PubMed  Google Scholar 

  120. Schölten, T., Fritsch, W.P., Hagenmüller, F. et al.: Die Behandlung des Ulcus duodeni mit Depot-Sekretin - eine multizentrische Doppelblindstudie. Z. Gastroenterol, (im Druck)

    Google Scholar 

  121. Scobie, B.A.: Gastric ulcer treatment with carbenoxolone sodium (“Biogastrone“). N. Z. Med. J. 65, 308–309 (1966)

    PubMed  CAS  Google Scholar 

  122. Shinagawa, F., Fujita, R., Hasegawa, Y.: Klinische Erfahrungen mit Proglumid (Milid) bei der Behandlung von peptischen Ulzera (Zusammenfassung). In: 9. Internationaler Kongress für Gastroenterologie, Paris (1972)

    Google Scholar 

  123. Smith, P.M., Sladan, G.E., Beck, E.R. et al.: A double-blind trial of carbenoxolone and geranyl farnesyl acetate in gastric ulcer. Scand. J. Gastroenterol. 10, 753 (1975)

    PubMed  CAS  Google Scholar 

  124. Soll, A.H.: Prostaglandin inhibition of histamin stimulated aminopyrine uptake and cyclic AMP generation by isolated canine parietal cells. Gastroenterology 74, 1146

    Google Scholar 

  125. Sonnenberg, A., Hunzinger, W., Koelz, H.R., Fischer, J.A., Blum, A.L.: Stimulation of endogenous cyclic AMP (cAMP) in isolated gastric cells by histamine and Prostaglandine. Acta Physiol. Scand. [Special Suppl.] 307–317 (1978)

    Google Scholar 

  126. Suga, S., Shimochi, H., Koide, K. et al.: Therapeutische Wirkung von Proglumid bei gastroduodenalen Ulzera. Clin. Rep. 4, 2703 (1970)

    Google Scholar 

  127. Sun, C.D.H.: Long-term anticholiniergic therapy for prevention of recurrence in duodenal ulcer. Am. J. Dig. Dis. 9, 706–716 (1964)

    Article  PubMed  CAS  Google Scholar 

  128. Sun, D.C., Ryan, M.L.: A controlled study on the use of propantheline and amylopectin sulphate (SN-263) for recurrences in duodenal ulcer. Gastroenterology 58, 756–761 (1970)

    PubMed  CAS  Google Scholar 

  129. Sun, D.C.H., Shay, H.: Optimal effective dose of anticholinergic drug in peptic ulcer therapy. Arch. Intern. Med. 97, 442 (1956)

    CAS  Google Scholar 

  130. Takeo, W., Katsuni, S., Satoru, O.: Medizinische Behandlung des Magenulcus. Doppelblindstudie über die klinische Anwendung von Proglumid. Nihon Rinsho 28, 2498 (1970)

    Google Scholar 

  131. Tete, R.: Stellung von Proglumid bei der Behandlung pathologischer Zustände im Magen und Duodenum. Actual. Ther. 51, 1227 (1975)

    Google Scholar 

  132. Tewari, S.N., Trembalowicz, P.B.: Some experience with deglycyrrhizinated liquorice in the treatment of gastric and duodenal ulcers with special reference to its spasmolytic effect. Gut 9, 48–51 (1968)

    Article  PubMed  CAS  Google Scholar 

  133. Tjodleifsson, B., Wormsley, K.G.: Aspects of the effect of metiamide on pentagastrin stimulated and basal gastric secretion of acid and pepsin in man. Gut 16, 501 (1975)

    Article  Google Scholar 

  134. Trevino, H., Anderson, J., Davey, P.G. et al.: Effect of glycopyrrolate on the course of symptomatic duodenal ulcer. Am. J. Dig. Dis. 12, 983–987 (1967)

    Article  PubMed  CAS  Google Scholar 

  135. Turpie, A.G.G., Thomson, T.J.: Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side effects. Gut 6, 591–594 (1965)

    Article  PubMed  CAS  Google Scholar 

  136. Van Trappen, G., Peeters, T.: Gastric antisecretory effect of tritiozine in normal volunteers. Riv. Gastroenterol. 30, 21 (1978)

    Google Scholar 

  137. Walan, A.: Studies on peptic ulcer disease with special reference to the effect of hyoscyamine. Acta Med. Scand. [Suppl.] 516, 1–57 (1970)

    CAS  Google Scholar 

  138. Weiss, J.: A double-blind clinical evaluation of the antihypersecretive action of proglumide in gastric secretion induced by pentagastrin and other stimulants. In: Antisecretory non-anticholinergic therapeutics in the ulcerative disease: New acquisitions, p. 119 ( Abstr.). Paris: L’Expansion Scientifique Française 1972

    Google Scholar 

  139. Wieck, H.H., Kallenberg, A., Liebler, G., Pauli, W., Posth, H.-E.: Klinische Untersuchungen zur Psychosomatik der Ulcuskrankheit. Neurologie 27, 133–160 (1959)

    CAS  Google Scholar 

  140. Wilson, J.A.C.: A comparison of carbenoxolone sodium and deglycyrrhizinated liquorice in the treatment of gastric ulcer in the ambulant patient. Br. J. Clin. Pract. 26, 563 (1972)

    PubMed  CAS  Google Scholar 

  141. Young, G.P., St. John, D.J.B., Conventry, D.A.: A double-masked endoscopic evaluation of carbenoxolone in duodenal ulcer: Further evidence for a beneficial effect. In: Peptio ulcer healing—Recent studies on carbenoxolone. Avery Jones, F., Langman, M.J.S., Mann, R.D. (eds.), pp. 117–125. Lancaster: MTP Press 1978

    Google Scholar 

Download references

Authors
  1. W.-P. Fritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik, Stadtspital Triemli, Birmensdorferstraße 497, CH-8063, Zürich, Switzerland

    André Louis Blum

  2. Klinikum rechts der Isar, der Technischen Universität München, Ismaninger Straße 22, D-8000, München 80, Germany

    Jörg Rüdiger Siewert (Direktor der Chirurgischen Klinik und Poliklinik) (Direktor der Chirurgischen Klinik und Poliklinik)

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fritsch, WP. (1982). Andere Sekretionshemmer und Medikamente zur Förderung der Schleimhautresistenz. In: Blum, A.L., Siewert, J.R. (eds) Ulcus-Therapie. Interdisziplinäre Gastroenterologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68477-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68477-7_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-68478-4

  • Online ISBN: 978-3-642-68477-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation